Patent 7323573 was granted and assigned to Kosan Biosciences on January, 2008 by the United States Patent and Trademark Office.
Recombinant Myxococcus host cells can be used to produce polyketides, including epothilone and epothilone analogs that can be purified from the fermentation broth and crystallized.